Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report
AUTOR(ES)
Hughes, Brett
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=524360Documentos Relacionados
- Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
- Blepharospasm and periorbital edema after imatinib mesylate: improvement with botulinum toxin
- Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect?
- Downstaging of a rectal gastrointestinal stromal tumor by neoadjuvant imatinib therapy allowing for a conservative surgical approach
- In vitro inhibitory effects of imatinib mesylate on stromal cells and hematopoietic progenitors from bone marrow